Fibroblasts neurotrophin signaling sustains pathological vascular maturation in rheumatoid arthritis.
Ethics
Ethics & Compliance Reviewer
SCORE: 5 CONFIDENCE: 5
Summary
This manuscript presents a comprehensive spatial transcriptomic analysis of synovial microvasculature in rheumatoid arthritis, identifying neurotrophin signaling as a driver of pathological vascular maturation that persists despite immunosuppressive therapy. The work is ethically sound, properly approved, and compliant with all relevant disclosure requirements. Human subjects research is appropriately documented with IRB approval and consent procedures clearly stated. No animal research, clinical trials, dual-use risks, or restricted-consent data issues are present. Funding sources and competing interests are fully disclosed.
Ethics & Compliance Assessment
Human subjects research: The manuscript describes synovial tissue samples obtained from two institutions with explicit IRB approvals named (Brigham and Women's Hospital MGB IRB no. 2019P002924 and Flinders Medical Center Protocol#396.10). The Materials and Methods section clearly states tissue collection procedures and storage protocols. No identifiable data are presented; all analyses are on de-identified tissue samples. This is compliant.
Funding and competing interests: The Acknowledgments section provides detailed funding attribution to NIH NIAMS grants (R01AR085028, K08AR077037), Arthritis Foundation, Burroughs Wellcome Fund, and institutional awards. No competing interests are declared, which is appropriate given the basic research nature of the work and absence of commercial relationships mentioned. This is compliant.
Clinical trial registration: Not applicable; this is basic research on tissue explants and cultured cells, not a clinical trial.
Animal research: Not applicable; no animal studies are reported.
Dual-use or biosafety concerns: Not applicable; the work involves standard cell culture and tissue analysis with no pathogenic agents or dual-use methodology.
Secondary or restricted-consent data: Not applicable; tissue samples are from routine clinical procedures (arthroplasty, synovectomy) with standard consent.
No compliance issues identified. The manuscript meets all required standards for human subjects research oversight and disclosure.